Cervical CancerNCT07620795
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
A study testing Web-Based Health Education in people with Cervical Cancer and HPV, run by Sakarya University.
Trial summary
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. Read more about this study
- Who is it for?
- Ages 18 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cervical Cancer, HPV
- What is being tested?
- Web-Based Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2026to 1 Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Having no prior clinical diagnosis of cervical cancer
- Being between 18 and 60 years of age
- Having active access to the internet
- Being literate at a level sufficient to read and understand the questionnaire forms
- Being capable of effectively navigating and using a web browser
- Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
- Volunteering to participate in the study and providing informed consent
Who cannot join
- Withdrawing from the study voluntarily at any stage
- Failing to watch the mandatory educational videos on the platform
- Submitting incomplete or incorrect responses to the data collection tools
- Lacking active internet access or proper web browser usage skills
- Criteria for Study Discontinuation / Drop-out:
- Participant's request to withdraw from the study
- Failure to respond to or complete the data collection tools
- Not using or logging into the web application for more than 2 consecutive weeks during the study period
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing.
Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.
- Conditions
- Cervical Cancer, HPV
- Being tested
- Web-Based Health Education
- Keywords
- HPV Testing, Health Education, Web-based learning, Attitudes and Beliefs
- Medical subject headings
- Uterine Cervical Neoplasms, Health Education, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-Based Health EducationBehavioural
Participants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model). Participants will also be provided with educational brochures and magnets. For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Participants in this group will receive access to the web-based health education platform developed for the study. Receives: Behavioral: Web-Based Health Education |
| control group | No intervention | Participants in this group will receive standard routine follow-up during the study. After the completion of the study data collection, the web-based health education platform will also be made accessible to this group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale
This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing. Scores range from 7 to 49. A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.
Measured: Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale
This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing. Scores range from 4 to 28. A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs
Measured: Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale
This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures. Scores range from 6 to 42. A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.
Measured: Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale
This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing. Scores range from 3 to 21. A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.
Measured: Baseline and 12 weeks post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 Jan 2027 (estimated)
- Study completion1 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervical CancerStudies of the same condition, open and under way.
- More trials run by Sakarya UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be stratified by age and randomly assigned using block randomization to either the intervention group, which receives web-based health education, or the control group, which receives standard follow-up without education.
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sakarya University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Icoz, Sakarya University
- Investigators
- ZEKİYE TURAN, Phd, Associate Professor, Study chair, Sakarya University Faculty of Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07620795
- Sponsor's protocol ID
- SAU-SBE-MI-01
- Status last verified
- Sep 2026
- First submitted
- 20 May 2026
- Last updated
- 22 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared to ensure and maintain participant confidentiality in accordance with the institutional ethics committee approval and local data protection regulations.
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING
- ClinicalTrials.gov ID
- NCT07620795
- Acronym / sponsor ID
- SAU-SBE-MI-01
- Conditions
- Cervical Cancer, HPV
- Keywords
- HPV Testing, Health Education, Web-based learning, Attitudes and Beliefs
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Sakarya UniversityUniversity, hospital or other
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 1 Feb 2027 (estimated)
- First posted
- 2 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing.
Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be stratified by age and randomly assigned using block randomization to either the intervention group, which receives web-based health education, or the control group, which receives standard follow-up without education.
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Behavioral: Web-Based Health EducationParticipants in this group will receive access to the web-based health education platform developed for the study. |
| control group | No intervention | –Participants in this group will receive standard routine follow-up during the study. After the completion of the study data collection, the web-based health education platform will also be made accessible to this group. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Having no prior clinical diagnosis of cervical cancer
- Being between 18 and 60 years of age
- Having active access to the internet
- Being literate at a level sufficient to read and understand the questionnaire forms
- Being capable of effectively navigating and using a web browser
Key exclusion criteria (8 listed)
- Withdrawing from the study voluntarily at any stage
- Failing to watch the mandatory educational videos on the platform
- Submitting incomplete or incorrect responses to the data collection tools
- Lacking active internet access or proper web browser usage skills
- Participant's request to withdraw from the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Web-Based Health EducationParticipants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model). Participants will also be provided with educational brochures and magnets. For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion. | Behavioural | Intervention Group |
Primary outcome
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale
Time frame: Baseline and 12 weeks post-intervention
This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing. Scores range from 7 to 49. A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale
Time frame: Baseline and 12 weeks post-intervention
This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing. Scores range from 4 to 28. A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale
Time frame: Baseline and 12 weeks post-intervention
This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures. Scores range from 6 to 42. A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale
Time frame: Baseline and 12 weeks post-intervention
This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing. Scores range from 3 to 21. A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared to ensure and maintain participant confidentiality in accordance with the institutional ethics committee approval and local data protection regulations.
Related trials for Cervical Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial
Head & Neck Cancer
RecruitingPhase 2/3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Oesophageal Cancer, Gastric Cancer
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 4
Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery
Head and Neck Cancer (H&N)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
ZEKİYE TURAN, Phd, Associate Professor study chair
Sakarya University Faculty of Health Sciences
Questions about this trial
What is this clinical trial studying?
A study testing Web-Based Health Education in people with Cervical Cancer and HPV, run by Sakarya University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact MERVE İÇÖZ, Phd Student, Msc Midwife (+905072094020, merve.icoz@ogr.sakarya.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale (time frame: Baseline and 12 weeks post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.